Print
Daewoong Pharmaceutical (069620)   STOCK
 
Address 223-23, SANGDAEWON 1-DONG, GYEONGGI
Home Page www.daewoong.co.kr
Established 2002.10. 2 Tel 031-741-7700
Listed 2002.11. 1 IR 02-550-8138
Common shares O/S 10,427,047 President Lee,Jong Uk/Yun,Jae Hun
Preferred shares O/S No.of Employees 1,260(2009. 9)
Sales of its key products such as Urso increased. Profitability declined as a weaker currency boosted import prices of raw materials. Financial status remained stable on the back of ample liquidity and low debt.
Sales of new products such as Zanubia are expected to increase, while demand for existing products is expected to wane down the road. Profitability improved as a stronger currency helps reduce costs of raw materials. Financial status is expected to remain stable on its good cash flows, although it plans facility investment.
(date: 2009.06, unit : %)
Name Daewoong Dae Woong Foundation Yoon Yeonghwan
Portion 40.2 5.0 3.4
(unit : %)
Sales Olmesartan medoxomil 14.7 Cost Raw Materials
Ursa 8.9 Labors
Others 56.4 Overhead
(Unit : 100Mn.Won,Won)
Year 02.11 08. 4 09. 4    -    -
Type LI BI BI
Amount 246.96  6.84  6.87